FREGAT FRESH-PEF8468-en Christophe MARIETTE FREGAT FRESH-PEF8468-en 8468 FRESH-PEF8468 Christophe MARIETTE CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE (CHU) Epidemiology France Portal (PEF) INSTITUT NATIONAL DU CANCER (INCA) null Tumour of the oesophagus stomach tumour diseases of the oesophagus digestive system diseases gastroesophageal cancer digestive system clinical and biological records surgery Oncology Gastroenterology Behavioral determinants Behavioral determinants: Eating habits Healthcare system determinants: Use of care Healthcare system determinants Main Objective: To identify, through the creation of a clinico-biological, prospective, multicentric French database, the clinical, biological and tumour factors linked to anti-tumour therapy resistance in patients treated for stage I to IV oesophageal or stomach cancer. Secondary Objectives: - To assess the impact of different current therapeutic strategies for recurrence, survival and quality of life. - To identify predictive factors for patient treatment resistance in order to identify the most efficient and least toxic therapeutic combination. - To describe individual, social and behavioural characteristics of patients included in the study. - To identify individual and collective determinants that influence possible access to care and initiation of treatment. - To identify new prognostic and predictive relapse factors. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Men or women ≥ 18 ans. - Presenting with oesophageal or gastro-oesophageal junction carcinoma recently diagnosed by biopsy, regardless of cancer subtype, tumour stage or proposed treatment. - Treatment-naive cancer. - Have given clear and written consent for blood samples, various questionnaires and the collection of patient information. N.B.: Patients participating in a clinical trial can be included in the FREGAT trial. There is no exclusion period. Clinical data Participant-reported health data Biological data Socio-demographic data Health event/morbidity Health event/mortality Health care consumption and services Quality of life/health perception Others Other Through organizations (health services or institutions schools businesses etc.) >= 20000 individuals Converting or copying information into a structured record Observational Study Observational Study Cohort study 135 patients au 20/01/2015 Unknown Restricted access Publication or presentation of results from this trial is not permitted without prior agreement from the sponsor (CHRU de Lille) and coordinating researcher. Access on specific project only